Pepsinogen I (PGI, PGA)
Product Name | Pepsinogen I |
Source | Human Gastric Mucosa |
Catalogue Number | 440-50 |
Purity | > 90% (SDS-PAGE) |
Purity Note | Typically > 96% (SDS-PAGE) |
Form | Lyophilized |
Protein | Reported mg protein/vial (A280nm, E0.1%=1.48) |
Specific Activity | > 500 U/mg protein (After activation) |
Unit Definition | One unit will produce a change in A280 of 0.001 per minute at pH 2.0 and 37°C, measured as TCA-soluble products from hemoglobin. |
Appearance | White to off-white powder |
Solubility | Clear, colorless liquid (1 mg/mL saline) |
Reconstitution | After reconstitution maintain at or above pH 8.0 to avoid activation. |
Formulation | Lyophilized from tris-chloride, pH 8.5. |
Related Products | 440-52 - Pepsinogen II from human gastric mucosa 441-10 - Pepsin 1:10,000 from porcine gastric mucosa 435-10 - Mucin from porcine gastric mucosa |
Recertification | 3 years |
Storage | -20°C |
Infectious Disease Testing | Negative or non-reactive at the donor level for anti HIV 1 and 2, anti HCV, syphilis (RPR) and HBsAg by FDA approved methods |
Molecular Weight | 40,300 |
Synonyms | Pepsinogen A, PG I, PGA, Pepsinogen 1 |
E.C. Number | 3.4.23.1 |
Gene | PGA3, PGA4, PGA5 |
Lee Biosolutions is the leading producer and supplier of human gastric Pepsinogen I (A) antigen as a cancer marker for medical research, clinical and biomedical manufacturing.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and are classified into two groups, Pepsinogen I and Pepsinogen II).
Human PGA and PGC antigen have been investigated as a possible biomarker for early detection of, Gastric cancer (GC), adenoma (GA) and severe atrophic (diffuse or patchy) corpus gastritis.
It has been reported that human Pepsinogen I (PGA) levels were lower in atrophic corpus gastritis than in atrophic antral gastritis, and human pepsinogen I(PGA) levels were lower in advanced gastric cancer than early stage gastric cancer.